258 - Late Breaking Clinical Trials

Moderator(s)

• 

  Carlos Del Rio, MD

  Executive Associate Dean
  Emory School of Medicine at Grady Health System
  Atlanta, GA, United States

  Disclosure(s): ACTHIV: Board Member (Ongoing); IAS-USA: Board Member (Ongoing); Mass Medical Society/NEJM: Section Chief, JournalWatch Infectious Diseases (Ongoing); Resverlogix: Advisor/Consultant (Ongoing)
• 

  Wendy Armstrong, MD

  Professor of Medicine (ID)
  Medicine
  Emory University School of Medicine
  Decatur, Georgia, United States

  Disclosure(s): No financial relationships to disclose

No CE Credit Offered

Presentations:

• 1:45 PM – 1:57 PM US ET

  Ceftobiprole Compared to Daptomycin With or Without Optional Aztreonam for the Treatment of Complicated Staphylococcus aureus (SAB): Results of a Phase 3, Randomized, Double-Blind Trial (ERADICATE)
  

  Presenting Author: Thomas L. Holland, MD – Duke University Medical Center

  Co-Author: Sara E. Cosgrove, MD – Johns Hopkins University Department of Medicine

  Co-Author: Sarah B. Doernberg, MD, MAS – University of California, San Francisco

  Co-Author: Oleksander Pavlov, MD – Zaycev V.T. Institute of General and Emergency Surgery of the National Academy of Medical Sciences of Ukraine, Kharkiv

  Co-Author: Ivan Titov, MD – Regional Clinical Hospital, Regional Clinical Hospital, Ivano-Frankivsk Regional Council

  Co-Author: Boyko Atanasov, MD – Eurohospital Plovdiv

  Co-Author: Maziar Assadi Gehr, MD – Basilea Pharmaceutica International Ltd

  Co-Author: Marc Engelhardt, MD – Basilea Pharmaceutica International Ltd

  Co-Author: Kamal Hamed, MD – Basilea Pharmaceutica International Ltd

  Co-Author: Daniel Ionescu, MD – Basilea Pharmaceutica International Ltd

  Co-Author: Mark Jones, PhD – Basilea Pharmaceutica International Ltd

  Co-Author: Mikael Sauley, MSc – Basilea Pharmaceutica International Ltd

  Co-Author: Jennifer Smart, PhD – Basilea Pharmaceutica International Ltd

  Co-Author: Harald Seifert, MD – Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne

  Co-Author: Timothy C. Jenkins, MD – Denver Health and Hospital Authority

  Co-Author: Nicholas A. Turner, MD, MHSc – Duke University Medical Center

  Co-Author: Vance G. Fowler, Jr, MD, MHS – Duke University Medical Center
• 1:57 PM – 2:09 PM US ET

  Single High-dose of Liposomal Amphotericin B in HIV/AIDS-related Disseminated Histoplasmosis: a Randomized Trial
  

  Presenting Author: Alessandro C. Pasqualotto, FECMM (he/him/his) – Universidade Federal de Ciencias da Saude de Porto Alegre

  Co-Author: Cassia M. Godoy, MD – Hospital de Doencas Tropicais

  Co-Author: Daiane Dalla Lana, PhD – Universidade Federal de Ciencias da Saude de Porto Alegre

  Co-Author: Terezinha S. Leitao, MD – Universidade Federal do Ceara

  Co-Author: Monica B. Bay, MD – Universidade Federal do Rio Grande do Norte

  Co-Author: Lisandra S. Damasceno, MD – Hospital Sao Jose

  Co-Author: Renata B. Soares, PhD – PUC de Goias

  Co-Author: Diego R. Falci, MD – PUCRS

  Co-Author: Roger Kist, PharmD – Santa Casa de Misericordia de Porto Alegre

  Co-Author: Larissa R. Silva, BsC – Universidade Federal de Ciencias da Saude de Porto Alegre

  Co-Author: Marineide Melo, MD – Hospital Nossa Senhora da Conceicao

  Co-Author: Taiguara F. Guimaraes, MD – Hospital de Doencas Tropicais

  Co-Author: Marilia R. Guimaraes, MD – Hospital de Doencas Tropicais

  Co-Author: Hareton T. Vechi, MD – Universidade Federal do Rio Grande do Norte

  Co-Author: Jaco Mesquita, MD – Hospital Sao Jose

  Co-Author: Erianna Y. Macedo, MD – Hospital Sao Jose

  Co-Author: Antoine A. Adenis, MD – Centre d'Investigation Clinique Antilles-Guyane

  Co-Author: Nathan C. Bahr, MD – University of Kansas

  Co-Author: Andrej Spec, MD, MSCI – Washington University in St. Louis

  Co-Author: David R. Boulware, MD, MPH, CTropMed – University of Minnesota

  Co-Author: Dennis Israelski, MD – Gilead Sciences

  Co-Author: Tom M. Chiller, MD – Centers for Disease Control and Prevention
• 2:09 PM – 2:21 PM US ET

  INHALE WP3: Results of a multi-centre randomised controlled trial (INHALE) testing the utility of rapid multiplex PCR at point-of-care for the antibiotic management of hospital-acquired and ventilator-associated pneumonia in critical care.
  

  Presenting Author: Virve Enne, BSc PhD (she/her/hers) – University College London

  Co-Author: Susan Stirling, MSc – University of East Anglia

  Co-Author: Julie Barber, BSc MSc PhD – University College London

  Co-Author: Juliet High, Masters in Chemistry – Norwich Clinical Trials Unit

  Co-Author: Charlotte Russell, BSc – University of East Anglia

  Co-Author: Kerry Dresser, BSc – University of East Anglia

  Co-Author: Zaneeta Dhesi, MBBS MD – University College London

  Co-Author: David Brealey, MBBSPhD – University College London Hospital

  Co-Author: Suveer Singh, MBBS PhD – Chelsea and Westminster Hospital

  Co-Author: Ann Marie Swart, MBBS – University of East Anglia

  Co-Author: David Livermore, BSc PhD – University of East Anglia

  Co-Author: Vanya Gant, MBBS PhD – University College London Hospital
• 2:21 PM – 2:33 PM US ET

  Long Term Benefits from Early Antiretroviral Therapy Initiation in HIV Infection: Findings from the Extended Follow-up of the START Trial
  

  Presenting Author: Abdel G. Babiker, PhD – University College London

  Co-Author: Jens Lundgren, MD DMSc – Rigshospitalet, University of Copenhagen

  Co-Author: Shweta Sharma, MS – University of Minnesota

  Co-Author: Birgit Grund, Ph.D. – University of Minnesota

  Co-Author: Andrew Phillips, PhD – UCL

  Co-Author: Virginia L. Kan, MD – VA Medical Center

  Co-Author: Gail Matthews, MBChB, PhD – Kirby Institute, UNSW

  Co-Author: Karin L. Klingman, MD – Medical Science and Computing

  Co-Author: James D. Neaton, PhD – University of Minnesota
• 2:33 PM – 2:45 PM US ET

  Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baumannii-calcoaceticus Complex (ABC) Infections
  

  Presenting Author: Sujata M. Bhavnani, PharmD; MS; FIDSA – Institute for Clinical Pharmacodynamics

  Co-Author: Christopher M. Rubino, PharmD – Institute for Clinical Pharmacodynamics

  Co-Author: Jeffrey P. Hammel, MS – Institute for Clinical Pharmacodynamics

  Co-Author: Anthony P. Cammarata, M.S. – Institute for Clinical Pharmacodynamics

  Co-Author: Kajal Larson, PhD – Entasis Therapeutics

  Co-Author: Kathryn Liolios, MA – Institute for Clinical Pharmacodynamics

  Co-Author: Sarah McLeod, PhD (she/her/hers) – Entasis Therapeutics

  Co-Author: Alita Miller, PhD – Entasis Therapeutics

  Co-Author: Paul G. Ambrose, PharmD; MS; FIDSA – Institute for Clinical Pharmacodynamics

  Co-Author: Ruben Tommasi, PhD – Entasis Therapeutics

  Co-Author: John O'Donnell, B.S – Entasis Therapeutics
• 2:45 PM – 2:57 PM US ET

  Safety and Efficacy of Letermovir (LET) versus Valganciclovir (VGCV) for Prevention of Cytomegalovirus (CMV) Disease in Kidney Transplant Recipients (KTRs): A Phase 3 Randomized Study
  

  Presenting Author: Ajit P. Limaye, MD – University of Washington Medical Center

  Co-Author: Klemens Budde, MD – Charité-Universitätsmedizin Berlin

  Co-Author: Atul Humar, MD, MSc, FRCPC – University Health Network

  Co-Author: Julia Garcia-Diaz, MD – Ochsner Medical Center

  Co-Author: Robert P. Carroll, BM BCh (Oxon), FRACP, DM (Oxon) – Central Northern Adelaide Renal and Transplantation Service

  Co-Author: Yoshihiko Murata, MD, PhD – Formerly Merck & Co., Inc.

  Co-Author: Valerie L. Teal, MS – Merck & Co., Inc.

  Co-Author: Christopher L. Gilbert, n/a – Merck & Co., Inc.

  Co-Author: Barbara A. Haber, MD – Merck & Co., Inc.